Literature DB >> 28500652

Freeze-dried plasma enhances clot formation and inhibits fibrinolysis in the presence of tissue plasminogen activator similar to pooled liquid plasma.

Benjamin R Huebner1, Ernest E Moore1,2, Hunter B Moore1, Angela Sauaia1,2, Gregory Stettler1, Monika Dzieciatkowska3, Kirk Hansen3, Anirban Banerjee1, Christopher C Silliman4,5.   

Abstract

BACKGROUND: Systemic hyperfibrinolysis is an integral part of trauma-induced coagulopathy associated with uncontrolled bleeding. Recent data suggest that plasma-first resuscitation attenuates hyperfibrinolysis; however, the availability, transport, storage, and administration of plasma in austere environments remain challenging and have limited its use. Freeze-dried plasma (FDP) is a potential alternative due to ease of storage, longer shelf life, and efficient reconstitution. FDP potentially enhances clot formation and resists breakdown better than normal saline (NS) and albumin and similar to liquid plasma. STUDY DESIGN AND METHODS: Healthy volunteers underwent citrated blood draw followed by 50% dilution with NS, albumin, pooled plasma (PP), or pooled freeze-dried plasma (pFDP). Citrated native and tissue plasminogen activator (t-PA)-challenge (75 ng/mL) thrombelastography were done. Proteins in PP, pFDP, and albumin were analyzed by mass spectroscopy.
RESULTS: pFDP and PP had superior clot-formation rates (angle) and clot strength (maximum amplitude) compared with NS and albumin in t-PA-challenge thrombelastographies (angle: pFDP, 67.9 degrees; PP, 67.8 degrees; NS, 40.6 degrees; albumin, 35.8 degrees; maximum amplitude: pFDP, 62.4 mm; PP, 63.5 mm; NS, 44.8 mm; albumin, 41.1 mm). NS and albumin dilution increased susceptibility to t-PA-induced hyperfibrinolysis compared with pFDP and PP (NS, 62.4%; albumin, 62.6%; PP, 8.5%; pFDP, 6.7%). pFDP was similar to PP in the attenuation of t-PA-induced fibrinolysis. Most proteins (97%) were conserved during the freeze-dry process, with higher levels in 12% of pFDP proteins compared with PP.
CONCLUSION: pFDP enhances clot formation and attenuates hyperfibrinolysis better than NS and albumin and is a potential alternative to plasma resuscitation in the treatment of hemorrhagic shock.
© 2017 AABB.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28500652      PMCID: PMC5567780          DOI: 10.1111/trf.14149

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  29 in total

1.  Plasma is the physiologic buffer of tissue plasminogen activator-mediated fibrinolysis: rationale for plasma-first resuscitation after life-threatening hemorrhage.

Authors:  Hunter B Moore; Ernest E Moore; Eduardo Gonzalez; Gregory Wiener; Michael P Chapman; Monika Dzieciatkowska; Angela Sauaia; Anirban Banerjee; Kirk C Hansen; Christopher Silliman
Journal:  J Am Coll Surg       Date:  2015-03-31       Impact factor: 6.113

2.  The evolving role of lyophilized plasma in remote damage control resuscitation in the French Armed Forces Health Service.

Authors:  Anne Sailliol; Christophe Martinaud; Andrew P Cap; Corinne Civadier; Benoit Clavier; Anne-Virginie Deshayes; Anne-Christine Mendes; Thomas Pouget; Nicolas Demazeau; Marine Chueca; François-Régis Martelet; Sylvain Ausset
Journal:  Transfusion       Date:  2013-01       Impact factor: 3.157

3.  Refreezing previously thawed fresh-frozen plasma. Stability of coagulation factors V and VIII:C.

Authors:  W H Dzik; M A Riibner; S K Linehan
Journal:  Transfusion       Date:  1989-09       Impact factor: 3.157

4.  Comparison of the hemostatic efficacy of low-volume lyophilized plasma reconstituted using sterile water, lactated Ringer's, normal saline, and Hextend solutions.

Authors:  Tim H Lee; Sean P McCully; Belinda H McCully; Claire Sands; David A Hampton; Scott G Louis; Beth Rick; Nathan Anderson; Jerome Differding; Martin A Schreiber
Journal:  J Trauma Acute Care Surg       Date:  2014-02       Impact factor: 3.313

5.  Tissue-type plasminogen activator (t-PA) is stored in Weibel-Palade bodies in human endothelial cells both in vitro and in vivo.

Authors:  Denise Huber; Elisabeth M Cramer; Jocelyne E Kaufmann; Paolo Meda; Jean-Marc Massé; Egbert K O Kruithof; Ulrich M Vischer
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

6.  Quality of freeze-dried (lyophilized) quarantined single-donor plasma.

Authors:  Jürgen Bux; Dieter Dickhörner; Edgar Scheel
Journal:  Transfusion       Date:  2013-04-15       Impact factor: 3.157

7.  Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration.

Authors:  Bryan A Cotton; John A Harvin; Vadim Kostousouv; Kristin M Minei; Zayde A Radwan; Herbert Schöchl; Charles E Wade; John B Holcomb; Nena Matijevic
Journal:  J Trauma Acute Care Surg       Date:  2012-08       Impact factor: 3.313

8.  Vitamin K-dependent coagulation factors and fibrinogen levels in FFP remain stable upon repeated freezing and thawing.

Authors:  Ofira Ben-Tal; Ety Zwang; Roza Eichel; Tanya Badalbev; Mara Hareuveni
Journal:  Transfusion       Date:  2003-07       Impact factor: 3.157

9.  Supernatant protein biomarkers of red blood cell storage hemolysis as determined through an absolute quantification proteomics technology.

Authors:  Angelo D'Alessandro; Monika Dzieciatkowska; Ryan C Hill; Kirk C Hansen
Journal:  Transfusion       Date:  2016-01-26       Impact factor: 3.157

10.  Proteomic characterization of freeze-dried human plasma: providing treatment of bleeding disorders without the need for a cold chain.

Authors:  Leif Steil; Thomas Thiele; Elke Hammer; Jürgen Bux; Monika Kalus; Uwe Völker; Andreas Greinacher
Journal:  Transfusion       Date:  2008-07-22       Impact factor: 3.157

View more
  3 in total

Review 1.  Fibrinolysis in trauma: a review.

Authors:  M J Madurska; K A Sachse; J O Jansen; T E Rasmussen; J J Morrison
Journal:  Eur J Trauma Emerg Surg       Date:  2017-09-16       Impact factor: 3.693

2.  Effects of Blood Components and Whole Blood in a Model of Severe Trauma-Induced Coagulopathy.

Authors:  Gregory R Stettler; Ernest E Moore; Geoffrey R Nunns; Marguerite Kelher; Anirban Banerjee; Christopher C Silliman
Journal:  J Surg Res       Date:  2020-12-02       Impact factor: 2.192

3.  28-day thawed plasma maintains α2 -antiplasmin levels and inhibits tPA-induced fibrinolysis.

Authors:  Gregory R Stettler; Ernest E Moore; Benjamin R Huebner; Geoffrey R Nunns; Hunter B Moore; Julia R Coleman; Marguerite Kelher; Anirban Banerjee; Christopher C Silliman
Journal:  Vox Sang       Date:  2020-09-07       Impact factor: 2.144

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.